The EU’s Biopolitical Governance of Advanced Therapy Medicinal Products

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)


This paper focuses on the specific example of the newly operational Regulation on Advanced Therapy Medicinal Products to explore the potential for biopolitics, an arena in which biocitizens can demand and contest the exercise of EU power over life. The paper shows how the discourses producing, organizing and orchestrating citizen participation in the EU’s governance of advanced therapies from above figure a ‘deficit model’ of citizens in need of education inter alia through their membership of patients’ associations who have membership of the Committee on Advanced Therapies established by the Regulation. Biocitizens are shown to be incorporated to service the EU’s legitimacy needs. The paper then warns against assuming biocitizens’ (self-) reflexivity ensures they do not reiterate and reinforce their construction within the ‘deficit model’ by unwittingly deploying the terms of their subjection. After which the paper highlights some elements that provide a rhetorical and operational opening for participation, and which therefore can be used by biocitizens to reconstruct their engagement with EU governance from below, the wider governance of advanced therapies, as well as in their self-governance.
Original languageEnglish
Pages (from-to)113-137
Number of pages25
JournalMaastricht Journal of European and Comparative Law
Issue number1
Publication statusPublished - 2009


Dive into the research topics of 'The EU’s Biopolitical Governance of Advanced Therapy Medicinal Products'. Together they form a unique fingerprint.

Cite this